1.57K
·
10-31
I opened $Schwab US Large-Cap ETF(SCHX)$ ,When the markets are down, SCHX is a great Index ETF as it covers 750 of the largest US companies in just 1 trade. At just USD 22.90, it is certainly one of the cheapest ways to invest in the US Big Caps! In the long term SCHX will continue to rise. SCHX has already risen 22.6% year todate. On top of that SCHX also pays dividends every 3 months. The current dividend yield is 1.21%. That is pretty good for an index ETF!
SCHX
10-31 03:55
USSchwab US Large-Cap ETF
| Side | Price | Realized P&L |
|---|---|---|
| Buy Open | 22.90 | +2.19% Holding |
615
·
10-31
I opened $BIDU 20241115 85.0 PUT$ ,Think Baidu is undervalued. While its core business is somewhat troubled, it is not so bad that the sky is falling.
974
·
10-31
Why GOOG Continues to Dominate with Strong Growth Potential
$Alphabet(GOOG)$ smashed expectations in its Q3 2024 earnings, achieving a robust 15% year-over-year revenue increase to $88.3 billion, with an EPS of $2.12 beating analysts' estimate of $1.84. These impressive numbers are more than just a snapshot of a successful quarter; they reflect Alphabet's ongoing commitment to AI innovation, diversified revenue streams, and robust performance in Google Services and Google Cloud. For the quarter, Alphabet’s total revenue jumped from $76.7 billion in 2023 to $88.3 billion in 2024, driven by a 13% rise in Google Services revenue and an impressive 35% boost in Google Cloud. Operating income climbed 34% to $28.5 billion, expanding the operating margin by 4.5 percentage points to 32%. This margin expansion is a
191
·
10-29
Alternative Assets Shine Amid Pre-Election Market Uncertainty
With only one week remaining before the U.S. presidential election, there’s a growing sense of uncertainty in the air. Investors are wondering how to position their money, bracing for the possibility of significant volatility and market shifts. While some hedge funds are making bold moves on so-called “Trump trades,” we at U.S. Global Investors see things differently. In fact, I share billionaire hedge fund manager Paul Tudor Jones’ recent outlook on gold and Bitcoin (which validates what I have been writing about for many years). Like him, we currently favor alternative assets as the smart play going forward. It’s not that we’re betting against stocks or the economy, which we believe will do well over time no matter who wins the White House next month. Nevertheless, the writing
426
·
10-25
Bulls Are Roaring!
Hello everyone! Today i want to share some macro analysis with you!1. $.SPX(.SPX)$ BULLS are roaring / kicking. The late October Slump didn't materialize; it looks like there is another set of 4th/5th waves to unfold, and my bearish read in mid-October was premature, since the small hiccup this week only registered 100+ points for SPX. Now, ATH in sight again.Follow me to learn more about analysis!!
590
·
10-25
TSLA, SMR, AMD, PLTR& COST Welcome Great Potential Here!
Hello everyone! Today i want to share some technical analysis with you!1. $Costco(COST)$ Breakout loading...2. $Palantir Technologies Inc.(PLTR)$ PEEKABOO!NEW ALL TIME HIGHS3. $Advanced Micro Devices(AMD)$ reports earnings in exactly five days...Let's see if Lisa Su can save this monthly breakout. 👀4. $NuScale Power(SMR)$ Nuclear energy name forming a high and tight flag off prior 52-week highs, declining volume pattern...Has that look. ☢️ 5. $Tesla Motors(TSLA)$ Nancy Pelosi really fumbled the bag on TSLA:Back in June, she sold her entire stake worth ~$450K.Since then, the stock
517
·
10-26
TMDX: One of the Strongest Moats in the Organ Transplant Market
One of my highest conviction names is reporting earnings on Monday -- here’s what you need to know 🧐 $TransMedics Group Inc.(TMDX)$ The growing demand for organ transplants has created a critical need in healthcare, and TransMedics is addressing it with its cutting-edge Organ Care System (OCS). This platform overcomes the limitations of traditional preservation methods by maintaining organs outside the body for extended periods. By simulating the body’s natural environment, the OCS keeps hearts, lungs, and livers viable longer, improving organ quality, expanding donor-recipient matches, and ultimately increasing transplant success rates. Its impact is significant --reducing wait times and saving more lives.Network Effect MoatTransMedics is not jus
TOPBarcode: The CEO tends to slow play ER to get the pops. A good opportunity to buy the dip now. Happy trading ahead! Cheers, BC 🍀
157
·
10-26
Daily Charts - Recession Risk?
1.Recession Risk? ...what about the opposite?With more and more central banks pivoting to rate cuts, previous headwinds are removed, tailwinds added... and "Resurgence Risk" is now well on the table!Image2.Here's how the typical valuation-extreme market peak/trough looks likePeaks see steady up and sudden stopTroughs see gradual and then swift declines and just as rapid turnarounds $.SPX(.SPX)$ $SPDR S&P 500 ETF Trust(SPY)$ $.IXIC(.IXIC)$ $NASDAQ 100(NDX)$ $Invesco QQQ(QQQ)$ $.DJI(.DJI)$ $GLOBAL
163
·
10-26
$ARKK - Thoughts On The 3-Month High Breakout
$ARK Innovation ETF(ARKK)$ - Thoughts On The 3-Month High Breakout (Intraday)I've been tracking the setup on ARKK for the past two months, even experiencing a failed stop-loss attempt on 9/27 after a two-month high didn't hold.Currently (as of writing), ARKK is trading at a three-month high, with $Invesco QQQ(QQQ)$ and $Technology Select Sector SPDR Fund(XLK)$ also gaining. My first instinct is to review the latest holdings breakdown, particularly to see how significant $Tesla Motors(TSLA)$ contributes to the current move.While TSLA makes up a significant 13% of the fund, I'm refrain from taking action due to the upcoming
429
·
10-26
China CSI300 & $HSI Futures - Making the Case for a Second Rally Leg
China CSI300 & $HSI(HSI)$ Futures - Making the Case for a Second Rally LegThe top seven 1-month gainers among ETF indices are primarily driven by the initial rally in Chinese stocks (5 out of 7);1. $Valkyrie Bitcoin Miners ETF(WGMI)$ (Bitcoin Miners) +27.6%2. $Global X China Consumer ETF(CHIQ)$ (China Consumer Discretionary) +20.4%3. $X-trackers Harvest CSI 300 China A-Shares Fund(ASHR)$ (China CSI300 A Shares) +20.1%4. $KraneShares CSI China Internet ETF(KWEB)$ (China Internet) +18.8%5. $SPDR S&P China ETF(GXC)$ (China SPDR S&
109
·
10-26
Daily Charts - NU, LIT, RBRK & GGLS
1. $Nu Holdings Ltd.(NU)$ YoY Growth (Quarterly Basis) EPS & Sales IndicatorImage2. $Global X Lithium & Battery Tech ETF(LIT)$ An Identical Case for a Second Rally Leg with Chinese namesImage3. $Rubrik Inc.(RBRK)$ Further Flagging Action As RequiredRemains in my stalk list. Be patientImage4. $Direxion Daily GOOGL Bear 1X Shares(GGLS)$ (Inverse $Alphabet(GOOG)$ $Alphabet(GOOGL)$ ) A Downside Technical Picture30th October Earnings AfterhoursImageDon't dwell on the negativity of your trade outcome. Focus on the quality of the decisio
189
·
10-26
IBM: A Reality Check
$IBM(IBM)$ ’s stock performance surged after its Q3 2024 earnings report, behaving more like a prominent AI software player than a tech giant with substantial legacy businesses, mainly in consulting. However, IBM’s traditional operations are unlikely to benefit significantly from the AI boom. Given another lackluster quarter, IBM might not be worth the bullish outlook.Stagnant Growth Amid AI PushDespite repeated promises of pivoting to growth sectors, IBM hasn’t achieved substantial sales momentum. The latest quarterly report revealed a revenue increase of only 1.5% year-over-year, falling short of expectations. IBM's AI software business shows promise, but with an existing $60 billion revenue base, adding a few billion won’t ignite substantial gro
456
·
10-31
TMDX: Why I double My Positions Twice!
Here's why I doubled my $TransMedics Group, Inc.(TMDX)$ position in the past 24 hours 👇 The growing demand for organ transplants has created a critical need in healthcare, and TransMedics is addressing it with its cutting-edge Organ Care System (OCS). This platform overcomes the limitations of traditional preservation methods by maintaining organs outside the body for extended periods. By simulating the body’s natural environment, the OCS keeps hearts, lungs, and livers viable longer, improving organ quality, expanding donor-recipient matches, and ultimately increasing transplant success rates. Its impact is significant --reducing wait times and saving more lives.Expanding with New MilestonesTransMedics isn't just keeping up with growth -- it’s le
769
·
10-31
Option Strategies: .SPX, QQQ& NVDA
Hello everyone! Today i want to share some option strategies with you!1.TRADE PLAN for Thursday ✅ $.SPX(.SPX)$ 13 consecutive days of consolidation above 5767. SPX is forming a longer base leading into the Election/FOMC next week. BE PATIENT. The market isn't ready for a move higher yet. It needs 5872 $Invesco QQQ(QQQ)$ tested 500 multiple times in the past 2 weeks but failed to get through. QQQ if it back tests near 493 and holds we can see 500 by Monday495C can work near 493 $NVIDIA Corp(NVDA)$ 8 days of consolidation near 140. NVDA above 145 can run to 163+ this year. Be patient, it's not quite ready yet.Follow me to learn more about analysis!!
2.04K
·
10-31
Aztech Q3 2024 profits crashed
Study company management team character is one of my investment fundamental. Aztech CEO has delisted a SGX company before, the private offer price was stingy. After Aztech was listed again, CEO was questioned by SGX one time, why COE salary was so high? The salary didn't match the company revenue size. From these two events, I realised that the management and retail investors weren't in a same boat. Retail investors will not get good results in long term if management team put his benefits in higher priority than share holders. I found a chance close this counter at minor profits. Shares of Aztech Global $Aztech Gbl(8AZ.SI)$
TOPAgreed. I think it's unwise to invest in companies that don’t prioritize their shareholders and employees. Such companies seem to drain resources without genuinely contributing to their growth. I wouldn't consider investing in such subpar companies—they're simply squeezing more money out of retail investors through IPO.
445
·
10-31
GOLD Fluctuates with Macro Economy Conditions
Hello everyone! Today i want to share some macro analysis with u!1. $Gold - main 2412(GCmain)$ Thursday (31 October) Asian morning trading, spot gold high narrow oscillation, currently trading at 2787.36 ！Gold prices on Wednesday again refreshed record highs to $2,789.89 per ounce, as uncertainty over the U.S. presidential election boosted safe-haven demand, and traders are also waiting for economic data to provide clues to the Federal Reserve's policy path.However, the U.S. economy grew solidly in the third quarter, with consumer spending growing at its fastest pace in a year and a half and inflation slowing sharply, continuing to break recessionary forecasts; this gave support to U.S. bond yields, making gold bulls wary.
497
·
10-31
$Crocs(CROX)$
306
·
10-31
$HighCom Ltd(HCL.AU)$ Ok ive talked about this stock a couple of times. Its an Australian company with subsidiaries in the USA. I first brought it when russia invaded ukraine. They make military helmets and body armor, and do drones as well. Im seriously anti war, but the stuff they make saves the lives of people that didn't start war, so i was fine investing in it. Shortly after i invested, the company Received the largest contract they had ever had to supply helmets and body armor to an anonymous buyer, and the cash was paid in advance in full. Obviously ukraine, but they could not disclose that. This was a game changer for the business but it took about 2 months for the market to pick the news up, and the stock skyrocketed eventually. T
462
·
10-31
I have BTC topping out @83850k zone, to complete a 5 wave count up, we "may" see a fake middle top around 76400k zone deep retrace then run to the 83850k zone currently btc is still in a macro trend extension after completing a standard 9 count to the high in June an open and close monthly new ATH needs to print to confirm the TD sequential count, which also would complete a macro 5 wave count from current cycle macro low, looking for a local divergence for a right side higher top also to complete topping pattern sequence
637
·
10-30
$Hershey(HSY)$ 🔺🅱🆄🅻🅻🅸🆂🅷🔺 Swing to $200 🍫🚀💵 HSY’s Sweet Ride to $200 – Swinging Strong in the Channel! 💵🚀🍫 Kia ora Tiger traders! 🍫 Let’s dive into Hershey Co. ($HSY), a stock that’s on a swing-filled journey with a shot at returning to $200! This tasty play brings together technical swing analysis, capital flow insights, and a look at the big players’ moves. Could this be the sweet spot for your portfolio? 📉 Channel Swing Setup: Pathway to $200 Hershey is currently trading at $181.00, up 0.54% overnight, showing early signs of strength! The price is moving within a descending channel with solid support around $178.82. The next resistance point is $222.47, making $200 a realistic target for this swing play. 🔸 Support: $178.82 🔸 Resistanc
TOPBased on the available information, there are several factors contributing to the movement of Hershey Co. ($HSY) stock: Sales Performance and Halloween Season: Analysts have reported a decline in Hershey's sales for the 4- and 12-week periods leading up to October 19 compared to the previous year. This suggests that Hershey may experience a weak Halloween season and has lost market share to other candy companies. The weak sales trends could potentially impact the company's financial performance. Capital Flow Analysis: The capital flow data for Hershey indicates a balance between inflows and outflows, with a total inflow of $65.82 million and a total outflow of $62.50 million on a single trading day. This suggests that there is ongoing activity and a potential balance of power between buyers and sellers. Analyst Recommendations: Analyst sentiment towards Hershey is mixed, with 2 analysts recommending a buy, 5 analysts recommending a hold, and 3 analysts recommending a sell. Some analysts have reduced their price targets slightly but still maintain a hold pattern with room for upside potential. Dividend Yield and Brand Strength: Hershey's dividend yield of 2.85% and brand strength are seen as positive factors by analysts, providing a potential cushion for long-term investors. However, the growth prospects for the company are seen as moderate. Market News and Initiatives: Hershey has recently inaugurated three public primary schools in Côte d'Ivoire as part of its commitment to cocoa-growing communities. While this initiative may not have an immediate impact on the stock's price, it reflects Hershey's efforts to expand access to education and support the communities involved in cocoa production. It's important to note that stock movements are influenced by multiple factors and can be subject to volatility. The information provided here is based on available data and news articles, and it's always recommended to conduct thorough research and analysis before making any investment decisions. Risk Disclaimer: The information provided here is for reference purposes only and does not constitute investment advice. Trading stocks involves risks, and it's important to carefully consider your investment objectives and risk tolerance before making any investment decisions.
Most Discussed
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial